|
|
Volumn 8, Issue 2, 2006, Pages 85-87
|
|
Hormones and heart disease in women: Where are we in 2005?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
ANTILIPEMIC AGENT;
CONJUGATED ESTROGEN;
CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE;
ESTRADIOL;
ESTROGEN;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
PLACEBO;
AGE;
BEHAVIOR MODIFICATION;
CLINICAL TRIAL;
CORONARY ARTERY ATHEROSCLEROSIS;
DRUG EFFICACY;
FEMALE;
GENERAL PRACTICE;
HEART PROTECTION;
HORMONAL THERAPY;
HUMAN;
HYPERLIPIDEMIA;
HYPERTENSION;
ISCHEMIC HEART DISEASE;
MEDICAL LITERATURE;
MEDICAL RESEARCH;
MENOPAUSE;
NOTE;
PRESCRIPTION;
RISK ASSESSMENT;
RISK BENEFIT ANALYSIS;
RISK REDUCTION;
SEX DIFFERENCE;
TREATMENT FAILURE;
TREATMENT OUTCOME;
UNITED STATES;
CLINICAL TRIALS;
CORONARY DISEASE;
ESTROGENS;
FEMALE;
HUMANS;
INCIDENCE;
MIDDLE AGED;
POSTMENOPAUSE;
RISK FACTORS;
|
|
EID: 33645064847
PISSN: 15233804
EISSN: None
Source Type: Journal
DOI: 10.1007/s11883-006-0043-7 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
